Who is eligible for clinical trial NCT07130708?

Participants must meet protocol criteria for Prostate Carcinoma. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT07130708 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2025-08-16

Exploring the Potential of Robotic Telesurgery in Remote Settings (NCT07130708)

🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: AdventHealth

🩺 Plain-English Summary (8th-Grade Level)

This study involves a type of robotic surgery called telesurgery, where a highly trained surgeon performs the surgical procedure using a secure internet connection to operate on a patient in a different location. Urologists from The goal of this study is to find out how safe and effective telesurgery is when used in real hospitals. The study aims to understand how well Telesurgery works in different settings, what technical challenges might come up (like internet speed or delays), and how it can be used to train new surgeons.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (8 items) and avoid the listed exclusions (10 items).

Location: AdventHealth — Celebration, Florida

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Age 18 - 90
Male or female
Eligible participants for this telesurgery study must have a clearly defined indication for robotic urologic surgery, specifically:
Localized Prostate Cancer (ICD-10: C61), appropriate for robotic radical prostatectomy. OR
Benign Prostate diseases appropriate for robotic simple prostatectomy (ICD-10: N40) These diagnoses are confirmed by clinical examination, imaging, and/or pathology prior to surgical planning. Patients with vague or unspecified urologic conditions will be excluded to ensure the safety and appropriateness of the surgical intervention.
Primary diagnosis of urinary system disease and prostate disorders (C61 and N40.1) scheduled to undergo treatment with robotic surgery. These patients don't have access to robotic surgery in their routine and the study will give them the opportunity to have advanced technology and the gold-standard treatment with experts in the field.
Willing to participate in the study
Mentally capable of comprehending the study protocol

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Patients who, based on multidisciplinary evaluation (surgical, anesthetic, and medical), are deemed not suitable for robotic surgery due to high perioperative risk. This includes but is not limited to:
Uncontrolled cardiovascular, pulmonary, or metabolic disease.
Severe anesthetic risk classified as ASA Class IV or higher.
Patients enrolled in another interventional research study that may interfere with surgical safety or outcomes.
Patients unwilling or unable to comply with the perioperative and follow-up schedule.
Vulnerable populations are excluded from this study, including:
Minors (under 18 years old)
Prisoners
Cognitively impaired or decisional incapacitated individuals

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

AdventHealth — Celebration, Florida

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗